BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

4 hedge funds and large institutions have $283K invested in ProShares UltraShort NASDAQ Biotechnology in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

48% less capital invested

Capital invested by funds: $542K → $283K (-$259K)

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$50.7K
2
+$11

Top Sellers

1
-$163K
2
-$42.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$273K
TRCT
2
Tower Research Capital (TRC)
New York
$10.1K
Morgan Stanley
3
Morgan Stanley
New York
$15
UBS Group
4
UBS Group
Switzerland
$9
CAG
5
Csenge Advisory Group
Florida
–